206 related articles for article (PubMed ID: 32196463)
1. Deciphering the expression dynamics of ANGPTL8 associated regulatory network in insulin resistance using formal modelling approaches.
Siddiqa A; Ahmad J; Ali A; Khan S
IET Syst Biol; 2020 Apr; 14(2):47-58. PubMed ID: 32196463
[TBL] [Abstract][Full Text] [Related]
2. Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways.
Siddiqa A; Cirillo E; Tareen SHK; Ali A; Kutmon M; Eijssen LMT; Ahmad J; Evelo CT; Coort SL
Genomics; 2017 Oct; 109(5-6):408-418. PubMed ID: 28684091
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells.
Rong Guo X; Li Wang X; Chen Y; Hong Yuan Y; Mei Chen Y; Ding Y; Fang J; Jiao Bian L; Sheng Li D
Exp Cell Res; 2016 Jul; 345(2):158-67. PubMed ID: 26387753
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers.
Xu F; Tian D; Shi X; Sun K; Chen Y
Pathol Oncol Res; 2021; 27():1609914. PubMed ID: 34646087
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL8 enhances insulin sensitivity by directly activating insulin-mediated AKT phosphorylation.
Zhang Z; Wu H; Dai L; Yuan Y; Zhu Y; Ma Z; Ruan X; Guo X
Gene; 2020 Jul; 749():144707. PubMed ID: 32344005
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases.
Abu-Farha M; Abubaker J; Tuomilehto J
Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28722798
[TBL] [Abstract][Full Text] [Related]
7. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like 8 (ANGPTL8) expression is regulated by miR-143-3p in human hepatocytes.
DiStefano JK
Gene; 2019 Jan; 681():1-6. PubMed ID: 30261196
[TBL] [Abstract][Full Text] [Related]
9. New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases.
Su X; Zhang G; Cheng Y; Wang B
Mol Biol Rep; 2021 Apr; 48(4):3761-3771. PubMed ID: 33864591
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-221-3p Regulates Angiopoietin-Like 8 (ANGPTL8) Expression in Adipocytes.
Mysore R; Ortega FJ; Latorre J; Ahonen M; Savolainen-Peltonen H; Fischer-Posovszky P; Wabitsch M; Olkkonen VM; Fernández-Real JM; Haridas PAN
J Clin Endocrinol Metab; 2017 Nov; 102(11):4001-4012. PubMed ID: 28938482
[TBL] [Abstract][Full Text] [Related]
11. TDAG51 Attenuates Impaired Lipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus Through SREBP-1/ANGPTL8 Pathway.
Wu X; Xiao B
Balkan Med J; 2023 May; 40(3):175-181. PubMed ID: 36960944
[TBL] [Abstract][Full Text] [Related]
12. The Proinflammatory Role of ANGPTL8 R59W Variant in Modulating Inflammation through NF-κB Signaling Pathway under TNFα Stimulation.
Abu-Farha M; Madhu D; Hebbar P; Mohammad A; Channanath A; Kavalakatt S; Alam-Eldin N; Alterki F; Taher I; Alsmadi O; Shehab M; Arefanian H; Ahmad R; Thanaraj TA; Al-Mulla F; Abubaker J
Cells; 2023 Nov; 12(21):. PubMed ID: 37947641
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL8 roles in proliferation, metabolic diseases, hypothyroidism, polycystic ovary syndrome, and signaling pathways.
Navaeian M; Asadian S; Ahmadpour Yazdi H; Gheibi N
Mol Biol Rep; 2021 Apr; 48(4):3719-3731. PubMed ID: 33864588
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ANGPTL8 in liver and adipose tissue by nutritional and hormonal signals and its effect on glucose homeostasis in mice.
Zhang L; Shannon CE; Bakewell TM; Abdul-Ghani MA; Fourcaudot M; Norton L
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E613-E624. PubMed ID: 32154742
[TBL] [Abstract][Full Text] [Related]
15. Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status.
Guo C; Zhao Z; Deng X; Chen Z; Tu Z; Yuan G
Endocr J; 2019 Dec; 66(12):1039-1046. PubMed ID: 31631098
[TBL] [Abstract][Full Text] [Related]
16. Loss of Glycine
Huang JW; Chen CJ; Yen CH; Chen YA; Liu YP
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470507
[TBL] [Abstract][Full Text] [Related]
17. ANGPTL8 negatively regulates NF-κB activation by facilitating selective autophagic degradation of IKKγ.
Zhang Y; Guo X; Yan W; Chen Y; Ke M; Cheng C; Zhu X; Xue W; Zhou Q; Zheng L; Wang S; Wu B; Liu X; Ma L; Huang L; Huang K
Nat Commun; 2017 Dec; 8(1):2164. PubMed ID: 29255244
[TBL] [Abstract][Full Text] [Related]
18. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.
Harada M; Yamakawa T; Kashiwagi R; Ohira A; Sugiyama M; Sugiura Y; Kondo Y; Terauchi Y
PLoS One; 2021; 16(7):e0255147. PubMed ID: 34293055
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL8 in cardio-metabolic diseases.
Su X; Cheng Y; Wang B
Clin Chim Acta; 2021 Aug; 519():260-266. PubMed ID: 34023284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
